David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YELL
2801
DELISTED
Yellow Corporation Common Stock
YELL
| $1.29M | ﹤0.01% |
1,876,247
-267,614
| -12% | -$418K |
|
|
TARO
2802
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.29M | ﹤0.01% |
34,066
-19,628
| -37% | -$616K |
|
2803
Antero Midstream
AM
$10.7B
| $1.29M | ﹤0.01% |
111,333
-167,586
| -60% | -$1.78M |
|
2804
Children's Place
PLCE
$59.4M
| $1.29M | ﹤0.01% |
55,619
+22,036
| +66% | +$560K |
|
2805
PUT
AeroVironment
AVAV
$7.46B
| $1.29M | ﹤0.01% |
+12,600
| New | +$1.27M |
|
|
MODV
2806
DELISTED
ModivCare
MODV
| $1.29M | ﹤0.01% |
+28,495
| New | +$1.69M |
|
2807
Edison International
EIX
$28.7B
| $1.28M | ﹤0.01% |
18,483
+13,960
| +309% | +$982K |
|
|
HTBK
2808
DELISTED
Heritage Commerce
HTBK
| $1.28M | ﹤0.01% |
154,487
-42,216
| -21% | -$335K |
|
|
SFBS
2809
ServisFirst Bancshares
SFBS
$4.74B
| $1.28M | ﹤0.01% |
62,374
+19,212
| +45% | +$444K |
|
2810
PTC
PTC
$16.5B
| $1.28M | ﹤0.01% |
+8,968
| New | +$1.19M |
|
2811
CALL
Weatherford International
WFRD
$6.31B
| $1.28M | ﹤0.01% |
19,200
+8,200
| +75% | +$505K |
|
2812
CALL
Coherent
COHR
$57.6B
| $1.27M | ﹤0.01% |
25,000
-5,000
| -17% | -$186K |
|
|
BCOV
2813
DELISTED
Brightcove, Inc.
BCOV
| $1.27M | ﹤0.01% |
317,501
+26,935
| +9% | +$109K |
|
2814
Crinetics Pharmaceuticals
CRNX
$9B
| $1.27M | ﹤0.01% |
+70,590
| New | +$1.41M |
|
2815
Kodak
KODK
$933M
| $1.27M | ﹤0.01% |
274,664
+161,783
| +143% | +$682K |
|
2816
GeoPark
GPRK
$630M
| $1.27M | ﹤0.01% |
127,787
-3,027
| -2% | -$31.9K |
|
|
CTRA
2817
CALL
DELISTED
Coterra Energy
CTRA
| $1.26M | ﹤0.01% |
+50,000
| New | +$1.24M |
|
2818
CALL
Fastly Inc
FSLY
$3.71B
| $1.26M | ﹤0.01% |
80,000
| – | – |
|
2819
Sensient Technologies
SXT
$5.83B
| $1.26M | ﹤0.01% |
17,716
-6,847
| -28% | -$508K |
|
2820
Alexandria Real Estate Equities
ARE
$9.12B
| $1.25M | ﹤0.01% |
11,053
-56,624
| -84% | -$6.74M |
|
2821
CALL
B&G Foods
BGS
$287M
| $1.25M | ﹤0.01% |
90,000
-12,000
| -12% | -$173K |
|
|
PNT
2822
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.25M | ﹤0.01% |
+138,174
| New | +$1.22M |
|
2823
CALL
Trupanion
TRUP
$1.32B
| $1.25M | ﹤0.01% |
+63,400
| New | +$1.79M |
|
2824
Stoke Therapeutics
STOK
$2.14B
| $1.24M | ﹤0.01% |
116,465
+50,496
| +77% | +$537K |
|
2825
PUT
Aehr Test Systems
AEHR
$2.97B
| $1.24M | ﹤0.01% |
+30,000
| New | +$984K |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.